Published in JAMA on May 23, 2007
Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA (2004) 14.17
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA (2009) 8.56
Impugning the integrity of medical science: the adverse effects of industry influence. JAMA (2008) 6.74
Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA (2005) 4.58
Clinical trial registration--looking back and moving ahead. N Engl J Med (2007) 4.07
Professors not professing. JAMA (2004) 3.91
Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med (2009) 2.46
Authorship for research groups. JAMA (2002) 2.10
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med (2003) 2.09
Clinical trial registration. BMJ (2007) 1.95
A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol (2006) 1.93
Clinical trial registration: looking back and moving ahead. Croat Med J (2007) 1.89
Postmarketing surveillance--lack of vigilance, lack of trust. JAMA (2004) 1.78
Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant (2007) 1.77
JAMA's policy on industry sponsored studies. BMJ (2006) 1.77
The influence of money on medical science. JAMA (2006) 1.68
Commitment to care for the community. JAMA (2009) 1.68
Basic science and translational research in JAMA. JAMA (2002) 1.66
Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis (2004) 1.56
Data requirements for electronic surveillance of healthcare-associated infections. Infect Control Hosp Epidemiol (2014) 1.53
Toward more uniform conflict disclosures--the updated ICMJE conflict of interest reporting form. N Engl J Med (2010) 1.52
Drugs alias dietary supplements. JAMA (2003) 1.49
Ensuring integrity in industry-sponsored research: primum non nocere, revisited. JAMA (2010) 1.47
The evolution of influenza resistance and treatment. JAMA (2009) 1.40
Update on JAMA's conflict of interest policy. JAMA (2006) 1.39
The Importance of Physicians' Financial Disclosure for the Public's Health. Milbank Q (2015) 1.38
Uniform format for disclosure of competing interests in ICMJE journals. N Z Med J (2009) 1.33
Mandatory HPV vaccination: public health vs private wealth. JAMA (2007) 1.25
Adamantane resistance in influenza A. JAMA (2006) 1.25
Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis (2008) 1.24
US Preventive Services Task Force and breast cancer screening. JAMA (2010) 1.18
Clinical trial registration: looking back and moving ahead. CMAJ (2007) 1.16
Clinical trial registration: looking back and moving ahead. JAMA (2007) 1.16
Uniform format for disclosure of competing interests in ICMJE Journals. Croat Med J (2009) 1.16
Clinical trial registration: looking back and moving ahead. Lancet (2007) 1.14
Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Arch Otolaryngol Head Neck Surg (2005) 1.07
Implementation of the ICMJE form for reporting potential conflicts of interest. JAMA (2010) 1.03
Effect of implementing safety-engineered devices on percutaneous injury epidemiology. Infect Control Hosp Epidemiol (2004) 1.01
Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol (2006) 0.99
Resolving unreported conflicts of interest. JAMA (2009) 0.97
Incomplete care--on the trail of flaws in the system. N Engl J Med (2011) 0.96
Uniform format for disclosure of competing interests in ICMJE journals. CMAJ (2009) 0.93
Pediatric chronic diseases--stealing childhood. JAMA (2007) 0.91
Uniform format for disclosure of competing interests in ICMJE journals. Lancet (2009) 0.88
Pseudo-outbreak of multidrug-resistant Mycobacterium tuberculosis associated with presumed laboratory processing contamination. Infect Control Hosp Epidemiol (2002) 0.87
Tuberculosis--a global problem requiring a global solution. JAMA (2005) 0.87
Update of the editorial governance plan for JAMA. JAMA (2004) 0.86
Development of automated quality reporting: aligning local efforts with national standards. AMIA Annu Symp Proc (2010) 0.84
Women's contribution to the health of the American population. Milbank Q (2015) 0.83
Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. JAMA (2010) 0.83
The need for regulation of dietary supplements--lessons from ephedra. JAMA (2003) 0.83
Malpractice risk in ambulatory settings: an increasing and underrecognized problem. JAMA (2011) 0.83
Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. Ann Intern Med (2010) 0.82
Peer Review and the Public's Health. Milbank Q (2015) 0.82
Translational medical research. JAMA (2003) 0.81
Heroism. JAMA (2002) 0.79
Toward more uniform conflict disclosures--the updated ICMJE reporting form for disclosure of potential conflicts of interest. Rev Med Chil (2010) 0.79
Correcting the literature--retraction and republication. JAMA (2005) 0.78
Conflicts of interest in medical practice and their costs to the nation's health and health care system. Milbank Q (2014) 0.78
Pain management. JAMA (2003) 0.77
Genetics and genomics for clinicians. JAMA (2008) 0.76
Update on JAMA-EXPRESS: rapid review and publication. JAMA (2008) 0.76
Medical research--state of the science. JAMA (2005) 0.76
Health promotion and disease prevention in children: it's never too early. JAMA (2009) 0.76
Child and adolescent health--a call for papers. JAMA (2008) 0.76
Prescription drugs, products liability, and preemption of tort litigation. JAMA (2008) 0.75
The electronic health record: boon or bust for good patient care? Milbank Q (2014) 0.75
Big Pharma Profits and the Public Loses. Milbank Q (2016) 0.75
Genetics and genomics: a call for papers. Arch Surg (2007) 0.75
Duplicate publication, multiple problems. JAMA (2004) 0.75
Health of the nation 2008 and beyond. JAMA (2008) 0.75
Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. N Z Med J (2010) 0.75
Pain management: a call for papers. JAMA (2002) 0.75
JAMA classics: celebrating 125 years of publication. JAMA (2008) 0.75
Disclosure of competing interests. BMJ (2009) 0.75
Frontal headache. JAMA (2011) 0.75
JAMA, National University Health System, Singapore, host diabetes, obesity meeting. JAMA (2008) 0.75
Pain management: a call for papers. Arch Intern Med (2002) 0.75
Pain management: a call for papers. Arch Pediatr Adolesc Med (2002) 0.75
Drugs for diabetes. Treat Guidel Med Lett (2005) 0.75
Pain management: a call for papers. Arch Neurol (2002) 0.75
Medical applications of biotechnology. JAMA (2005) 0.75
Preserving confidentiality in the peer review process. JAMA (2008) 0.75
Progress in infectious disease and immunology. JAMA (2011) 0.75
Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. Dan Med Bull (2010) 0.75
Toward more uniform conflict disclosures: the updated ICMJE Conflict of Interest Reporting Form. Chin Med J (Engl) (2010) 0.75
Access to care as a component of health system reform. JAMA (2007) 0.75
Access to JAMA. JAMA (2004) 0.75
Toward more uniform conflict disclosures--the updated ICMJE conflict of interest reporting form. Tidsskr Nor Laegeforen (2010) 0.75
Rainbow to dark clouds. JAMA (2005) 0.75
Women's health--advances in knowledge and understanding. JAMA (2006) 0.75
Towards more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form. Med J Aust (2010) 0.75
Uniform format for disclosure of competing interests in ICMJE journals. JAMA (2009) 0.75
The power of hope. JAMA (2008) 0.75
Update on JAMA's Policy on Release of Information to the Public. JAMA (2008) 0.75
The importance of the journal embargo. JAMA (2002) 0.75